Application 761139

Type
BLA
Sponsor
DAIICHI SANKYO

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761139Enhertufam-trastuzumab deruxtecan-nxki351(a)Rx2026-09-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ENHERTUFAM-TRASTUZUMAB DERUXTECAN-NXKIINJECTABLE;INJECTION100MGYesNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EnhertuFAM-TRASTUZUMAB DERUXTECAN-NXKIDaiichi Sankyo Inc.7e67e73e-ddf4-4e4d-8b50-09d7514910b62026-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761139
ndc (product): 65597-406

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 10 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo, Inc.BLACurrent
65597-406Enhertufam-trastuzumab deruxtecan-nxkiDaiichi Sankyo Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
86001SUPPL 2026-05-21
86000SUPPL 2026-05-21
85978SUPPL 2026-05-19
85977SUPPL 2026-05-19
85966SUPPL 2026-05-19
85965SUPPL 2026-05-19
85794SUPPL 2026-05-01
85793SUPPL 2026-05-01
84496SUPPL 2025-12-22
84494SUPPL 2025-12-22
84460SUPPL 2025-12-18
84459SUPPL 2025-12-18
81168SUPPL 2025-02-07
81166SUPPL 2025-02-07
80923SUPPL 2025-02-05
80922SUPPL 2025-02-05
80852SUPPL 2025-01-15
78079SUPPL 2024-04-08
78077SUPPL 2024-04-05
77526SUPPL 2024-02-16
77510SUPPL 2024-02-16
76574SUPPL 2023-11-15
72576SUPPL2022-11-07
72568SUPPL2022-11-07
71794SUPPL2022-08-12
71779SUPPL2022-08-11
71778SUPPL2022-08-11
71776SUPPL2022-08-11
71741SUPPL2022-08-08
71005SUPPL2022-05-06
71004SUPPL2022-05-06
70998SUPPL2022-05-04
70996SUPPL2022-05-04
70995SUPPL2022-05-04
67009SUPPL2021-04-09
65917SUPPL2021-01-15
65916SUPPL2021-01-15
61604ORIG2020-01-17
61515ORIG2020-01-15
61369ORIG2019-12-20